Improving glaucoma management

Article

Researchers have found that giving patients a dual therapy of bimatoprost and a beta-blocker is an effective method of lowering intraocular blood pressure (IOP) in patients with open-angle glaucoma.

Researchers have found that giving patients a dual therapy of bimatoprost and a beta-blocker is an effective method of lowering intraocular blood pressure (IOP) in patients with open-angle glaucoma.

The study consisted 89 patients with an IOP of less than 21 mm Hg. During six weeks the group were given latanoprost 50 mcg plus timolol 5 mg/mL, these patients were randomized to either travoprost plus timolol or bimatoprost plus timolol for three months before switching to the opposite therapy for an additional three months.

This study has been published in the American Journal of Ophthalmology

Related Videos
Ana Neves, head of global marketing for ZEISS Meditec Ophthalmology
Fritz Hengerer, MD, PhD, Director, Eye Hospital at Bürgerhospital, Frankfurt, Germany
Dr Sheng Lim, professor of glaucoma studies at St Thomas' Hospital, London
Kasperi Kankare at the iCare booth at ESCRS
Scott D Barnes, MD, CMO of STAAR Surgical
Tomislav Bucalic, head of marketing at Geuder, and David Geuder, member of the executive board and CIO
Related Content
© 2023 MJH Life Sciences

All rights reserved.